ClinConnect ClinConnect Logo
Search / Trial NCT02817568

Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP

Launched by ABANT IZZET BAYSAL UNIVERSITY · Jun 28, 2016

Trial Information

Current as of May 07, 2025

Completed

Keywords

Aggressive Periodontitis C C Chemokine Receptor 2 Gene Expression Monocyte Chemoattractant Protein 1, Restriction Fragment Length Polymorphism

ClinConnect Summary

Differences in structure of gene or non genetic factors such as nutrition/environmental factors may alter functional gene product: mRNA/protein which play crucial roles in immune system. This can lead developing defective immune responses, exacerbation of current inflammation and increased host susceptibility to inflammatory diseases. Monocyte functions can be critical with regard to getting individuals susceptible to periodontitis. Similarly Garrison and Nichols (1989) reported that hyper-inflammatory monocyte phenotype can be deterministic in periodontal destruction. For this reason, regu...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Periodontally H control group had \< 3mm PD, \< 2 GI and no signs of interproximal attachment loss and a history of periodontal disease.
  • The AgP group included individuals diagnosed with localized AgP (LAgP) or generalized AgP (GAgP) who were otherwise healthy. Periodontal attachment loss ≥4 mm not involving more than two permanent teeth, other than the first molars and incisors were diagnosed with LAgP (n: 43); patients with involvement of at least three teeth, other than the first molars and incisors with an attachment loss ≥4 mm were diagnosed with GAgP
  • Exclusion Criteria:
  • Patients who have any systemic diseases or conditions that could effect the periodontium
  • hepatitis and/or immunodeficiency virus infection
  • a history of periodontal treatment and antibiotic therapy within the 6 months
  • \< 16 teeth in their mouth
  • Subjects who had smoked and were ongoing orthodontic treatment were excluded.

About Abant Izzet Baysal University

Abant Izzet Baysal University is a prominent academic institution located in Turkey, dedicated to advancing education, research, and innovation in various fields, including healthcare and clinical studies. The university actively engages in clinical trials to contribute to medical knowledge and improve patient care, leveraging its robust infrastructure and expert faculty. With a commitment to ethical research practices and collaboration with healthcare professionals, Abant Izzet Baysal University aims to enhance the understanding of diseases and develop effective therapeutic interventions, fostering a strong link between academia and clinical application.

Locations

Patients applied

0 patients applied

Trial Officials

Nilgun O Alptekin, Phd, DDS

Principal Investigator

Baskent University, Faculty of Dentistry, Periodontology Department

Sadiye Gunpinar, Phd, DDS

Principal Investigator

Abant Izzet Baysal University, Faculty of Dentistry, Periodontology Department

Hasan Acar, Phd

Principal Investigator

Selcuk University, Faculty of Medicine, Department of Genetics

Vasfiye B Ucar, Phd

Principal Investigator

Selcuk University, Faculty of Medicine, Department of Genetics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials